(PharmaNewsWire.Com, July 06, 2017 ) The Asia-pacific Bovine Respiratory Disease Treatment Market has been estimated at USD 3.92 million in 2016 and is projected to reach USD 14.58 million by 2021, at a CAGR of 30.05% during the forecast period from 2016 to 2021. In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.
BRD is more than just a disease. It’s a respiratory disease complex which combines disease organisms with management and environment stressors. There are a number of built-in stressors such as transition stress, feed changes and environmental exposures. These stressors combine with disease organisms and advance into a complex that challenges an animal’s health.
In current scenario, cattle producers are trying to maximize the performance of each animal. Bovine respiratory disease (BRD) is a challenge to all cattle producers. There are many types of infectious agents involved. These agents not only cause severe pneumonia but also swollen, painful joints in calves.
The Asia-Pacific bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Asia-Pacific is geographically segmented into China, India, Japan, South Korea and Australia.
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
